Skip to main content
. 2022 Jan 13;71(8):1889–1896. doi: 10.1007/s00262-021-03121-0

Fig. 1.

Fig. 1

Therapeutic efficacy of lenvatinib combined with PD-1 in patients with gallbladder cancer. A Maximum percentage change in the sum of the diameters of the target lesions from baseline. B Kaplan–Meier estimation of progression-free survival of the entire cohort. C Kaplan–Meier estimation of overall survival of the entire cohort